ArticleCancer research2023

Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.

Alison E Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.